Bioinformatics construction of the human cell surfaceome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 39, 2009, Pages 16752-16757

  Da Cunha, J P C ^a   Galante, P A F ^a   De Souza, J E ^a   De Souza, R F ^a   Carvalho, P M ^a   Ohara, D T ^a   Moura, R P ^a   Oba Shinja, S M ^b   Marie, S K N ^b   Silva Jr , W A ^b   Perez, R O ^c   Stransky, B ^b   Pieprzyk, M ^d   Moore, J ^d   Caballero, O ^e   Gama Rodrigues, J ^c   Habr Gamad, A ^c   Kuo, W P ^f   Simpson, A J ^e   Camargo, A A ^a   Old, Lloyd J ^e   De Souza, S J ^a   more..

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^d FLUIDIGM CORPORATION   (United States)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Colorectal tumors; CT antigens; Glioblastoma; Transmembrane; Tumor cell surface antigens

Indexed keywords

CELL SURFACE PROTEIN; MEMBRANE PROTEIN;

ARTICLE; BIOINFORMATICS; COLORECTAL TUMOR; DNA POLYMORPHISM; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, SURFACE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; EPIGENESIS, GENETIC; GENETIC VARIATION; GLIOBLASTOMA; HUMANS; MEMBRANE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EUKARYOTA;

EID: 70349744048     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0907939106     Document Type: Article

References (40)

1. Rettig WJ, Old LJ (1989) Immunogenetics of human cell surface differentiation. Annu Rev Immunol 7:481-511. (Pubitemid 19138021)
2. Clark HF, et al. (2003) The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment. Genome Res 13:2265-2270.
3. Diehn M, Bhattacharya R, Botstein D, Brown PO (2006) Genome-scale identification of membrane-associated human mRNAs. PLoS Genet 2:e11.
4. Finn RD, et al. (2008) The Pfam protein families database. Nucleic Acids Res 36:D281-D288.
5. Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. J Mol Biol 305:567-580. (Pubitemid 33032862)
6. Davis MJ, et al. (2006) Differential use of signal peptides and membrane domains is a common occurrence in the protein output of transcriptional units. PLoS Genet 2:e46.
7. Jongeneel CV, et al. (2005) An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res 15:1007-1014.
8. Simpson AJ, et al. (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5:615-625.
9. Boon K, et al. (2002) An anatomy of normal and malignant gene expression. Proc Natl Acad Sci USA 99:11287-11292. (Pubitemid 34920918)
10. Muto M, et al. (2007) Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci 98:1570-1576. (Pubitemid 47308452)
11. Hamada A, et al. (2008) Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 14:3312-3318.
12. Abe T, et al. (2001) LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120:1689-1699. (Pubitemid 32523487)
13. Wood LD, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
14. Xie J, et al. (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391:90-92. (Pubitemid 28079221)
15. Lee SW, Moskowitz MA, Sims JR (2007) Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med 19:445-451.
16. Adolphe C, Hetherington R, Ellis T, Wainwright B (2006) Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res 66:2081-2088. (Pubitemid 43294917)
17. Athar M, et al. (2004) Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res 64:7545-7552. (Pubitemid 39372099)
18. Madi L, et al. (2004) The A3 adenosine receptor is highly expressed in tumor versus normal cells: Potential target for tumor growth inhibition. Clin Cancer Res 10:4472-4479. (Pubitemid 38878891)
19. Wang J, et al. (2008) Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 7:280-285. (Pubitemid 351302522)
20. Guerra E, et al. (2008) A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68:8113-8121.
21. Rettig WJ, et al. (1992) Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. Proc Natl Acad Sci USA 89:10832-10836.
22. St CB, et al. (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202.
23. Simonavicius N, et al. (2008) Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 21:308-315. (Pubitemid 351304285)
24. Shen MR, et al. (2004) Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells. J Biol Chem 279:40017-40025.
25. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
26. Arron JR, Walsh MC, Choi Y (2002) TRAF-mediated TNFR-family signaling. Curr Protoc Immunol Chapter 11:Unit 11.9D.
27. Schwandner R, Yamaguchi K, Cao Z (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191:1233-1240. (Pubitemid 30207685)
28. Zheng M, et al. (2008) Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2. Cancer Res 68:7570-7578.
29. Cheng SM, et al. (2007) Interferon-gamma regulation of TNFalpha-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells. Int J Cancer 121:1190-1196.
30. Balkwill F, Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357:539-545. (Pubitemid 32173595)
31. Mantovani G, et al. (2000) Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 78:554-561. (Pubitemid 32039615)
32. Gschwind A, Hart S, Fischer OM, Ullrich A (2003) TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22:2411-2421. (Pubitemid 36604980)
33. Coulie PG, et al. (2001) A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3. Proc Natl Acad Sci USA 98:10290-10295.
34. Gnjatic S, et al. (2006) NY-ESO-1: Review of an immunogenic tumor antigen. Adv Cancer Res 95:1-30. (Pubitemid 44088423)
35. Lee SY, et al. (2004) Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun 4:13.
36. Lee SY, et al. (2003) Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 100:2651-2656.
37. Ha C, et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102:6092-6097. (Pubitemid 40594260)
38. Scanlan MJ, et al. (2006) Glycoprotein A34, a novel target for antibody-based cancer immunotherapy. Cancer Immun 6:2.
39. Galante PA, Sakabe NJ, Kirschbaum-Slager N, de Souza SJ (2004) Detection and evaluation of intron retention events in the human transcriptome. RNA 10:757-765. (Pubitemid 38529738)
40. Galante PA, et al. (2007) Sense-antisense pairs in mammals: Functional and evolutionary considerations. Genome Biol 8:R40.